Download PDF
Semin Respir Crit Care Med 2002; 23(5): 471-480
DOI: 10.1055/s-2002-35718
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

What Is the Natural History of Resolution of Nosocomial Pneumonia?

Carlos M. Luna1 , Michael S. Niederman2,3
  • 1Pulmonary and Critical Care Divisions, Department of Medicine, Hospital de Clínicas ``José de San Martín,'' Universidad de Buenos Aires
  • 2Winthrop-University Hospital, Mineola, New York
  • 3Department of Medicine, SUNY at Stony Brook, New York
Further Information

Publication History

Publication Date:
25 November 2002 (online)

    Permissions and Reprints

ABSTRACT

Little is known about the natural history of resolution of nosocomial pneumonia, and thus it is likely that we are not always using the optimal duration of therapy in all patients. For some patients, with few risk factors for a poor outcome, and infection with easily treated pathogens, we can probably treat with a more abbreviated course of therapy than is commonly used. For other patients with risk factors for a poor outcome, and infection with ``high risk'' pathogens such as Pseudomonas aeruginosa, we may need longer durations of therapy. We review the clinical and microbiological definitions of resolution, including improvement, delayed resolution, relapse, or recurrent infection. There are also microbiological end points for resoution including eradication, persistence, and superinfection. The clinical parameters that affect resolution are patient related, microbiological, and treatment related, and these factors are summarized here. Currently, the time course of resolution is being defined using clinical end points such as the clinical pulmonary infection score (CPIS) and microbiological end points such as quantitative cultures of respiratory secretions. The hope for the future is to be able to identify whether the clinical response is adequate, at the earliest posible time point. This may allow for interventions to help the nonresponding patient, or shorten the duration of therapy in the responding patient.

KEYWORDS

Nosocomial pneumonia - Pseudomonas aeruginosa, ventilator-associated pneumonia - antibiotic resistance - pneumonia resolution

REFERENCES

  • 1 Vincent J L, Bihari D J, Suter P M. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study.  JAMA . 1995;  274 639-644
    CrossrefPubMedGoogle Scholar
  • 2 Heyland D K, Cook D J, Griffith L, Keenan S P, Brun-Buisson C. The attributable morbidity and mortality of ventilator associated pneumonia in the critically ill patient.  Am J Respir Crit Care Med . 1999;  159 1249-1256
    CrossrefPubMedGoogle Scholar
  • 3 Hernandez C, el-Ebiary M, Gonzalez J, de la Bellacasa P J, Monton C, Torres A. Relationship between ventilator-associated pneumonia and intramucosal gastric pHi: a case-control study.  J Crit Care . 1996;  11 122-128
    CrossrefPubMedGoogle Scholar
  • 4 Luna C M, Vujacich P, Niederman M S. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.  Chest . 1997;  111 676-685
    CrossrefPubMedGoogle Scholar
  • 5 Niederman M. Bronchoscopy in non-resolving nosocomial pneumonia.  Chest . 2000;  117(suppl) S121-S218
    PubMedGoogle Scholar
  • 6 Lowenkron S, Niederman M S. Definition and evaluation of the resolution of nosocomial pneumonia.  Semin Respir Infect . 1992;  7 271-281
    PubMedGoogle Scholar
  • 7 Timsit J F, Chevret S, Valcke J. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools.  Am J Resp Crit Care Med . 1996;  154 116-123
    CrossrefPubMedGoogle Scholar
  • 8 Bregeon F, Papazian L, Visconti A, Gregoire R, Thirion X, Gouin F. Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia.  JAMA . 1997;  277 655-662
    CrossrefPubMedGoogle Scholar
  • 9 Craven D E, Kunches L M, Kilinsky V. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.  Am Rev Respir Dis . 1986;  133 792-798
    PubMedGoogle Scholar
  • 10 Celis R, Torres A, Gatell J M. Nosocomial pneumonia: a multivariate analysis of risk and prognosis.  Chest . 1988;  93 318-324
    PubMedGoogle Scholar
  • 11 Torres A, Aznar R, Gatell J M. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.  Am Rev Respir Dis . 1990;  142 523-528
    CrossrefPubMedGoogle Scholar
  • 12 Malangoni M, Crafton R, Mocek F C. Pneumonia in the surgical intensive care unit: factors determining successful outcome.  Am J Surg . 1994;  167 250-255
    CrossrefPubMedGoogle Scholar
  • 13 Rello J, Ausina V, Ricart M. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.  Chest . 1993;  104 1230-1235
    CrossrefPubMedGoogle Scholar
  • 14 Kollef M H. Ventilator associated pneumonia: a multivariate analysis.  JAMA . 1993;  270 1965-1970
    PubMedGoogle Scholar
  • 15 Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit.  Chest. . 1995;  107 511-516
    CrossrefPubMedGoogle Scholar
  • 16 Graybill J R, Marshall L W, Charache P. Nosocomial pneumonia: a continuing major problem.  Am Rev Respir Dis . 1973;  108 1130-1140
    PubMedGoogle Scholar
  • 17 Kollef M H, Silver P, Murphy D M, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality.  Chest . 1995;  108 1655-1662
    CrossrefPubMedGoogle Scholar
  • 18 Kollef M H, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.  Chest . 1999;  115 462-474
    CrossrefPubMedGoogle Scholar
  • 19 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis assessment of severity, initial antimicrobial therapy and preventative strategies: a consensus statement, American Thoracic Society, November 1995.  Am J Respir Crit Care Med . 1996;  153 1711-1725
    PubMedGoogle Scholar
  • 20 Rello J, Torres A, Ricart M. Ventilator-associated pneumonia by Staphylococcus aureus: comparision of methicillin-resistant and methicillin-sensitive episodes.  Am J Resp Crit Care Med . 1994;  150 1545-1549
    CrossrefPubMedGoogle Scholar
  • 21 Bryan C S, Reynolds K L. Bacteremic nosocomial pneumonia: analysis of 172 episodes froma a single metropolitan area.  Am Rev Respir Dis . 1984;  129 168-171
    PubMedGoogle Scholar
  • 22 Fagon J Y, Chastre J, Hance A J, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.  Am J Med . 1993;  94 281-288
    CrossrefPubMedGoogle Scholar
  • 23 Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, Coll P. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?.  Am J Resp Crit Care Med . 1998;  157 912-916
    PubMedGoogle Scholar
  • 24 Dennesen P J, van der Ven J A, Kessels A G, Ramsay G, Bonten M JM. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia.  Am J Respir Crit Care Med . 2001;  163 1371-1375
    CrossrefPubMedGoogle Scholar
  • 25 Mosoni P, Langer M, Cigada M, Mandelli M. Epidemiology and risk factors of pneumonia in the critically ill patients.  Eur J Epidemiol . 1991;  7 320-327
    CrossrefPubMedGoogle Scholar
  • 26 Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, Schiaffino-Cana S, Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit.  Crit Care Med . 1994;  22 55-60
    PubMedGoogle Scholar
  • 27 Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman M S. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa Clin Infect Dis .  1996;  23 973-978
    PubMedGoogle Scholar
  • 28 Pittet D, Woolson R F, Wenzel R P. Microbiological factors influencing the outcome of nosocomial bloodstream infection: a 6-year, validated, population-based model.  Clin Infect Dis . 1997;  24 1068-1078
    PubMedGoogle Scholar
  • 29 Luna C, Videla A, Matera J. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia (VAP).  Chest . 1999;  116 1075-1084
    CrossrefPubMedGoogle Scholar
  • 30 Leu H S, Kaiser D L, Mori M, Woolson R F, Wenzel R P. Hospital acquired pneumonia: atributable mortality and morbidity.  Am J Epidemiol . 1989;  129 1258-1267
    PubMedGoogle Scholar
  • 31 Joshi N, Localio A R, Hamory B. A predictive risk index for nosocomial pneumonia in the intensive care unit.  Am J Med . 1992;  93 135-142
    CrossrefPubMedGoogle Scholar
  • 32 Chastre J, Vaugnat A, Joly-Guillou M L, Clavier H, Dombret M C, Gilbert C. Nosocomial pneumonia in patients with acute respiratory distress syndrome.  Am J Resp Crit Care Med . 1998;  157 1165-1172
    PubMedGoogle Scholar
  • 33 Baker A M, Meredith J W, Haponik E F. Pneumonia in intubated trauma patients: microbiology and outcomes.  Am J Respir Crit Care Med . 1996;  153 343-349
    PubMedGoogle Scholar
  • 34 Fagon J Y, Chastre J, Domart Y. Nosocomial pneumonia in patients receiving continuous mechanical ventilation.  Am Rev Respir Dis . 1989;  139 877-884
    PubMedGoogle Scholar
  • 35 Crouch Brewer S, Wunderink R G, Jones C B, Leeper Jr V K. Ventilator-associated pneumonia due to Pseudomonas aeruginosa Chest .  1996;  109 1019-1029
    PubMedGoogle Scholar
  • 36 Prod'hom G, Leuenberger P, Koerfer J. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial.  Ann Intern Med . 1994;  120 653-662
    PubMedGoogle Scholar
  • 37 Trouillet J L, Chastre J, Vuagnat A. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.  Am J Respir Crit Care Med . 1998;  157 531-539
    CrossrefPubMedGoogle Scholar
  • 38 Kollef M. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.  Clin Infect Dis . 2000;  S131-S138
    PubMedGoogle Scholar
  • 39 Vanhems P, Lepape A, Savey A. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival.  J Hosp Infect . 2000;  45 98-106
    CrossrefPubMedGoogle Scholar
  • 40 Brunson M, Meduri G U, Leeper K V, Wunderink R G, Stanley T, Tolley E. Pneumonia in ARDS: diagnostic and prognostic value of bilateral bronchoscopic sampling [abstract].  Am Rev Respir Dis . 1993;  147 A355
    PubMedGoogle Scholar
  • 41 Luna C M, Nogueira F, Videla A. Bronchoalveolar lavage (BAL) fluid quantitative culture and mortality in patients with severe pneumonia in the ICU [abstract].  Am J Respir Crit Care Med . 1998;  157 A695
    PubMedGoogle Scholar
  • 42 Souweine B, Veber B, Bedos J P. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.  Crit Care Med . 1998;  26 236-244
    CrossrefPubMedGoogle Scholar
  • 43 Carmeli Y, Troillet N, Karchmer A W, Samore M H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa Arch Intern Med .  1999;  159 1127-1132
    PubMedGoogle Scholar
  • 44 Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group.  Intensive Care Med . 1996;  387-394
    CrossrefPubMedGoogle Scholar
  • 45 Rello J, Gallego M, Mariscal D, Sonara R, Valles J. The role of routine microbial investigation in ventilator-associated pneumonia.  Am J Respir Crit Care Med . 1997;  156 196-200
    PubMedGoogle Scholar
  • 46 Kollef M H, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia.  Chest . 1998;  113 412-420
    CrossrefPubMedGoogle Scholar
  • 47 Sanchez-Nieto J M, Torres A, Garcia-Cordoba F. Impact of invasive versus invasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.  Am J Respir Crit Care Med . 1998;  157 371-376
    CrossrefPubMedGoogle Scholar
  • 48 Ruiz M, Torres A, Ewig S. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.  Am J Respir Crit Care Med . 2000;  162 119-125
    CrossrefPubMedGoogle Scholar
  • 49 Rello J, Ricart M, Ausina V, Net A, Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients: incidence, outcome, and risk factors.  Chest . 1992;  102 1562-1565
    PubMedGoogle Scholar
  • 50 Niederman M S. The principles of antibiotic use and the selection of empiric therapy for pneumonia. In: Fishman A, ed. Pulmonary Diseases and Disorders 3rd ed. New York: McGraw-Hill 1997: 1939-1949
    Google Scholar
  • 51 Hatala R, Dinh T, Cook D J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta analysis.  Ann Intern Med . 1996;  124 717-725
    PubMedGoogle Scholar
  • 52 Hanes S D, Wood G C, Herring V. Intermittent and continuous ceftazidime infusion for critically ill trauma patients.  Am J Surg . 2000;  179 436-440
    CrossrefPubMedGoogle Scholar
  • 53 Pugin J, Auckenthaler R, Mili N, Janssens J P, Lew P D, Suter P M. Diagnosis of ventilator-associated pneumonia by bacteriological analysis of bronchoscopic and nonbronchoscopic ``blind'' bronchoalveolar lavage fluid.  Am Rev Respir Dis . 1991;  143 1121-1129
    CrossrefPubMedGoogle Scholar
  • 54 Garrard C S, A'Court C D. The diagnosis of pneumonia in the critically ill.  Chest . 1995;  108(suppl) S17-S25
    PubMedGoogle Scholar
  • 55 Singh N, Rogers P, Atwood C W, Wagener M M, Yu V L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription.  Am J Respir Crit Care Med . 2000;  162 505-511
    CrossrefPubMedGoogle Scholar
  • 56 Dreyfuss D, Mier L, Le Bordelles G. Clinical significance of borderline quantitative protected specimen culture results.  Am Rev Respir Dis . 1993;  147 946-951
    PubMedGoogle Scholar
  • 57 Montravers P, Fagon J Y, Chastre J. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.  Am Rev Respir Dis . 1993;  147 38-44
    PubMedGoogle Scholar
  • 58 Luna C M, Blanzaco D, Niederman M. Resolution of ventilator-associated pneumonia: a prospective evaluation of early clinical predictors of outcome (in press).  Crit Care Med . 2002; 
    PubMedGoogle Scholar
      >